Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/78534, first published .
Infographic detailing a lung cancer screening trial: population, design, and outcomes.

Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial

Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial

Bo An   1 , MD ;   Jietao Lin   1, 2 , MD ;   Jingrui Wang   3 , MMed ;   Zhiqiang Chen   1 , MD ;   Minyi Guan   1 , MD ;   Yanlong Li   3 , MMed ;   Xiangjun Qi   3 , MD ;   Lingling Sun   1 , MD ;   Lizhu Lin   1 , MD

1 The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China

2 Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

3 Guangzhou University of Chinese Medicine, Guangzhou, China

Corresponding Author:

  • Lizhu Lin, MD
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine
  • No. 16 Airport Road, Baiyun District
  • Guangzhou 510400
  • China
  • Phone: 86 15625210828 ext 15625210828
  • Email: gzucmlinlz@163.com